Browsing Tag
CX-5461
2 posts
Senhwa Biosciences expands CX-5461 into photodynamic therapy as AACR 2026 spotlight raises strategic optionality
Senhwa Biosciences expands CX-5461 into photodynamic therapy. Discover how this dual-mechanism strategy could reshape oncology innovation today.
Senhwa Biosciences strikes pivotal supply deal with BeOne Medicines for cold tumor breakthrough
Senhwa Biosciences and BeOne Medicines announce a global clinical trial to tackle cold tumors. Find out how this deal could change cancer immunotherapy.